Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Hormon Receptor Positive Breast Cancer”

3 trials

Showing 3 of 3 results

Not applicableStudy completedNCT07072013
What this trial is testing

An Indirect Treatment Comparison of the Effectiveness of Ribociclib Combined With Non-steroidal Aromatase Inhibitors vs. Tamoxifen for the Adjuvant Treatment of Premenopausal Women With Hormon Receptor-positive, HER2-negative Early Breast Cancer

Who this might be right for
Breast Cancer
Novartis Pharmaceuticals 1,937
Testing effectiveness (Phase 2)Looking for participantsNCT07195227
What this trial is testing

Efficacy and Safety of Camizestrant Plus Ribociclib in Patients With Breast Cancer

Who this might be right for
Hormon Receptor Positive Breast CancerBreast Cancer
MedSIR 150
Not applicableStudy completedNCT01208779
What this trial is testing

Epidemiology Study in Postmenopausal Women With Estrogen Receptor Positive Breast Cancer

Who this might be right for
Hormon Receptor Positive Breast Cancer
AstraZeneca 90

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation